New York A 705: Relates to the availability of buprenorphine in opioid treatment programs

Status: PRINT NUMBER 705B (as of 2022-04-27)

State: New York · Session: 2021-2022 · Bill: A 705

Sponsors: ROSENTHAL L

View New York A 705 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.